Azatepa

This classification denotes an ethylenimine compound with the molecular formula C8H14N5OPS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D57I4Z650L, chemically known as p,p-bis(1-aziridinyl)-n-ethyl-n-1,3,4-thiadiazol-2-ylphosphinic amide but more generally known as azatepa, which bears US NIH Compound Identifier 31321. European Medicines Agency schedules Azatepa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05646MIG. The term AZATEPA is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). AZATEPA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule azatepa under HS 29349990 and SITC 51579. SMILES: CCN(C1=NN=CS1)P(=O)(N2CC2)N3CC3.